VigiLanz Announces L. Hayley Burgess, Pharm.D, MBA, BCPP, CPPS as New Chief Clinical Officer

Proven industry leader brings substantial clinical expertise and patient safety insights to further support company growth and innovation, while exceeding hospital client expectations

 

hayley burgessMINNEAPOLIS, August 9, 2021 — VigiLanz, a life-saving clinical surveillance company, today announced that Dr. L. Hayley Burgess has been named as the organization’s new Chief Clinical Officer. In this role, Dr. Burgess will provide leadership oversight and strategic vision for the VigiLanz clinical teams, as well as lead regulatory affairs activities, and support clinical innovations and product development.

Dr. Burgess has more than two decades of pharmacy services, patient safety, and medication management system experience and has spearheaded successful initiatives to enhance medication safety and risk mitigation, most recently served as AVP, Pharmacy Services for HCA Healthcare. In this role, she developed the pharmacy services and medication management strategy and vision for 185 hospital and 120 ambulatory surgery center programs.

While at HCA, her accomplishments included leading the antimicrobial management program (achieving a yearly fifty percent antimicrobial drug spend reduction over baseline), leading the clinical pharmacist workflow program that reduced coded adverse drug events by sixty percent, and improving financial resiliency related to high-cost medications (resulting in millions of dollars in drug spend waste). Her team recently won the Institute for Safe Medication Practices (ISMP) Cheers Award for the Clinical Pharmacist Workflow Model.

Previously she served as Director of Performance Improvement at TMIT, a medical research organization, and as a Supervisor of Clinical Pharmacy Specialties at Kaiser Permanente Colorado Division.

“We are excited to have a clinician as experienced and talented as Hayley join our leadership team. Her recent leadership role at one of the nation’s largest healthcare providers—and her many accomplishments in pharmacy and care delivery system leadership—speaks to her ability to augment with unparalleled knowledge, innovation and strategy,” said David Goldsteen, Chairman and CEO. “She has a broad, real-world vision and extensive knowledge that will greatly contribute to our team as we continue to push the boundaries to improve patient outcomes, clinical efficiency and operational efficiency.”

Dr. Burgess serves as a charter member of the Tennessee Hospital Association’s Medication Use and Safety Innovations Committee and Adverse Drug Event Prevention taskforce, in addition to a charter member of the Board of Pharmacy Specialties Employer committee. She is also part of the CDC and Harvard Pilgrim research team leading the INSPIRE trial for smart antimicrobial decision prompts for prescribers.

Dr. Burgess earned her Doctor of Pharmacy degree from Samford University and her Healthcare MBA from Western Governors University. She completed a post-doctoral residency and clinical science research fellowship in Neurobiology and Psychiatric Pharmacology/Pharmacoeconomics at the University of Texas Health Science Center in San Antonio. She is a Board-Certified Psychiatric Pharmacist (BCPP) and is a Certified Professional in Patient Safety (CPPS). Dr. Burgess is also an affiliate faculty member at Lipscomb University, the University of Tennessee, and Belmont University’s College of Pharmacy.

“I am honored to join the exceptional VigiLanz leadership team and further the mission of providing innovative clinical surveillance services to the healthcare industry,” said Dr. Burgess. “The dynamic software solutions we provide save lives, mitigate harm, and positively impact clinical services in hospitals and clinics with an intuitive workflow design. I am committed to our future success and the leadership role our organization’s technology solutions play in redefining clinical workflows, providing exceptional services and designing the future of patient safety event surveillance. VigiLanz’ ability to design meaningful clinical and safety measures, trends, and dashboards for healthcare system consumption is revolutionary!”

 

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient and outpatient care.

 

###

For More Information

John Gonda
(616)-309-4888
jgonda@sage-growth.com

Safety Event Detection and Management: 3 Things Every Hospital Needs

Most hospitals use basic safety event reporting mechanisms to monitor safety events and identify improvement opportunities. But the effectiveness of these mechanisms is often hindered by three key barriers:

  1. Lack of automated event detection  
  2. Cumbersome documentation workflows 
  3. Limited reporting and analytics capabilities 

When safety event reporting solutions lack these three features, events are less likely to be reported in a timely manner. Worse, many safety events may be missed altogether. That means hospitals are more likely to experience the same safety problems in the future.  

Here’s more on how your hospital can overcome the three key barriers outlined above. 

Barrier #1: Lack of automated event detection  

Why it’s a problem: In most hospitals, the only method to capture and report safety events is through staff member reporting. This single-method approach often results in delayed reporting and failure to report events at all. For example, staff may not have time to report events, forget to report them, or choose not to report them due to fear of punitive action. 

How to overcome it: Automated event detection 

What it is: Automated event detection, also known as electronic case finding, is the process of identifying safety events that have occurred using software algorithms and/or rules engines. This process, which can be used in combination with staff reporting, ensures more safety events are captured more quickly. 

Automated event detection requires near-real time standardized and normalized data. Cases are found using numerous types of data feeds including, but not limited to, the EMR, nursing notes, imaging, diagnosis and problem lists, medication administrations, and more.  

The best event auto-detection solutions capture all types of safety events, including those that affect patients, employees, and visitors.  

 

Automated Event Detection In Action: Narcan Example

VigiLanz Safety Surveillance uses several criteria to automatically detect safety events. For example, if the following criteria are met for the use of Narcan, a safety event is documented: 

  1. The administration of Narcan in a patient who has recently received morphine. 
  2. The patient has evidence of respiratory depression via a decrease in respiratory rate or oxygen saturation. 
  3. The patient is not currently located in a procedure area where the use of Narcan is more routine.  

Barrier #2: Cumbersome documentation workflows 

Why it’s a problem: Event reporting should not be difficult for your staff members. The harder it is for them to document events, the more likely it is that they will document them incorrectly or won’t document them at all. Cumbersome workflows also increase the likelihood that the reporting will lack the thoroughness necessary to support investigative processes. 

How to overcome it: Event form auto-population 

What it is: The same data feeds used to automatically detect safety events can also help streamline documentation workflows for staff members. When real-time standardized and normalized data is pulled from these data feeds, that data can be populated into event reporting forms automatically. This significantly reduces staff time spent filling out event forms.

This real-time data can provide additional benefits, including enhanced reporting accuracy and more efficient communication regarding safety events. For example, if certain thresholds are met, the solution can automatically trigger real-time alerts to relevant staff members.    

“Identifying patient safety opportunities is a fundamental first step to preventing harm and improving patient care, which is why hospitals promote safety event reporting.”

– James Hoffman, PharmD, Chief Patient Safety Officer, St. Jude Children’s Research Hospital

Barrier #3: Limited reporting and analytics capabilities 

Why it’s a problem: In order to foster continual safety improvements, the safety event reporting mechanism must make it easy for healthcare leaders to investigate and act on documented information via reporting and analytics tools. Unfortunately, this is another area in which many safety event reporting mechanisms fall short. 

How to overcome it: Automated event detection + form auto-population + reporting tools 

What it is: As previously noted, automated event detection and form auto-population are critical to ensuring safety events are identified quickly and documented properly. However, these capabilities are also key to enabling the quick and thorough analysis and investigation of safety events. 

Without automated event detection and auto-population, even the best safety event reporting and analytics platforms stumble. Since organizations without automated detection and auto-population tend to capture fewer events and fewer details related to events, their reporting and analytics platforms are working with incomplete data. That means these organizations are missing key safety trends and improvement opportunities. 

When automated event detection is used in tandem with a robust set of reporting and analytics tools—such as timelines, cause mapping, solution maps, and fishbone diagrams—hospitals can identify more safety events and safety trends more quickly. This helps them intervene faster to prevent future problems. 

“Hospitals increasingly recognize that they must find ways to intervene more quickly when safety events occur. The longer the delay in intervention, the more likely it is a similar event will occur again. Automated event detection and alerts keep patients safer because hospitals can intervene faster.”

– Karen Biesack, Senior Quality and Safety Specialist, VigiLanz

VigiLanz Dynamic Safety Surveillance is a modern, configurable platform for identifying, reporting, managing, and communicating safety events. By incorporating the above capabilities, VigiLanz enables organizations promote a culture of safety while reducing adverse events. Learn more at vigilanzcorp.com/safety-surveillance.

VigiLanz Launches Intelligent Audit Solution for Hospitals, Streamlining and Automating Processes and Expanding #1 Rated Clinical Surveillance Platform

Configurable forms, automated workflows, and real-time reports help hospitals and health systems strengthen quality oversight and scale quality improvement initiatives  

MINNEAPOLIS, June 29, 2021 — VigiLanz, a clinical surveillance company, today announced the launch of a new audit solution built on VigiLanz’s award-winning enterprise software platform. The new solution, VigiLanz Audit, complements VigiLanz’s existing safety, quality, and risk products by streamlining, automating, and optimizing audit processes. In addition to saving time and resources, VigiLanz Audit helps hospitals quickly identify emerging risks and ensure continuous quality improvements.

Recently recognized as Best in KLAS for Infection Control and Monitoring and Pharmacy Surveillance for the fourth consecutive year, VigiLanz applied its more than 20 years of complex, clinical data experience to create VigiLanz Audit.

The solution streamlines the full audit lifecycle, including case identification, data collection and analysis, and decision-making. It helps create and maintain an efficient, repeatable audit process, so hospitals can effectively evaluate improvement initiatives and scale programs when appropriate.

“VigiLanz Audit helps address significant challenges hospitals face related to time-consuming, inconsistent, and resource-burdensome audits,” said Stacy Pur, VigiLanz’s VP of Product Development, noting that many hospitals still rely on paper- and excel-based audit workflows.

VigiLanz Audit helps hospitals complete audits more efficiently and accurately, and as a result, they have more bandwidth to expand their audit and quality improvement programs.

“Previously, hospitals were only able to make improvements as fast as their manual processes and limited staffing resources would allow. Our new solution is a game-changer for patient safety and patient quality. It leads to a cycle of continuous improvement,” said Pur.

VigiLanz Audit supports every type of quality assurance (QA) and quality improvement (QI) healthcare audit, including clinical, environmental, billing compliance, and accreditation readiness. Key features include:

  • A comprehensive library of ready-to-go and configurable audit forms
  • Automated identification of eligible cases and automated case reminders
  • Accurate and repeatable processes
  • One-click population queries to determine appropriate sample size
  • Auto-populated forms and conditional form fields
  • Seamless data integration
  • Real-time audit reports and dashboards for enterprise-wide visibility

The launch of VigiLanz Audit follows the release of three other VigiLanz solutions: VigiLanz Risk and ClaimsVigiLanz Compliance, and VigiLanz Patient Relations. Learn more about these solutions, and VigiLanz Audit, at VigiLanzcorp.com.

VigiLanz earned Best in KLAS in the “2021 Best in KLAS: Software and Services” report, released February 2, 2021. Over the past four years, VigiLanz has earned 10 KLAS awards for its solutions.


About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.



Media Contact
John Gonda
(616)-309-4888
jgonda@sage-growth.com

VigiLanz Chairman and CEO David Goldsteen, MD, speaks with Health Professional Radio

Clinical Surveillance for Hospitals and Health Systems

By Health Professional Radio

Dr. David Goldsteen, Chairman and CEO of VigiLanz, discusses key findings from our third annual survey, revealing hospitals’ top patient priorities, benchmarked over time.  He talks about steps health leaders can take to address patient and staff safety—from getting ahead of potential infections and outbreaks, medication errors and antibiotic overuse, to preventing safety events, such as falling.  As COVID numbers continue to decline in most markets and hospital capacities are normalizing, now is the time to reevaluate current processes and procedures that can help mitigate avoidable safety issues.

Listen to the podcast

The pandemic’s enduring, positive impact on patient safety | Star Tribune

By David Goldsteen, CEO of VigiLanz.

A few months before COVID-19 turned our country upside down, the health care industry celebrated the 20th anniversary of the Institute of Medicine’s landmark report “To Err is Human.” The report — which noted that medical errors cause between 44,000 and 98,000 deaths every year — increased awareness regarding the rate of preventable errors and commenced a nationwide push to prevent them.

In an article commemorating the anniversary, Dr. Mark Chassin, president and CEO of the Joint Commission, which accredits U.S. hospitals and sets rigorous safety standards, wrote, “It’s been 20 years, and we haven’t moved the quality and safety needle as much as we had hoped.”

As an emergency medicine physician, I’ve seen firsthand the high rate of preventable medical errors. I agree with Chassin. I also can’t help wondering whether the industry would have moved faster to make patient safety improvements had it known what would hit the U.S. in February 2020.

After more than 575,000 deaths in the U.S. alone due to COVID-19, I believe the answer is yes. We would have moved faster.

Read more from the original article on the Star Tribune.

Insights from Real Hospitals: The Margin-Enhancing Benefits of Patient Safety

We recently released results from an economic value assessment of clinical surveillance by healthcare consultancy Sage Growth Partners. The results were extremely exciting, but not surprising to us here at VigiLanz, nor to our customers.

The assessment found that most hospitals could save millions of dollars by implementing VigiLanz.

For more on how the assessment was created, check out our economic value calculator. And, to learn how much your hospital could save, use the calculator to receive an instant, customized analysis. The tool requires you to input only a few data points, such as annual inpatient admissions, number of staffed beds, and daily census.

Hundreds of hospitals across the country can attest to the margin-improving benefits of VigiLanz. For example, we help hospitals identify IV to PO conversion opportunities; enhance management of high-cost drugs; and prevent costly events such as hospital acquired infections, adverse drug events, and readmissions.

Here are a few examples of hospitals experiencing significant savings due to VigiLanz:

freeman health system logo

Freeman Health System

Freeman Health System, a 485-bed, three-hospital system in Missouri, uses VigiLanz to support and streamline its medication reconciliation efforts. Since adopting the new approach, Freeman has completed an average of 1,400 medication reconciliations monthly. This has prevented nearly 30 potential major adverse drug events and more than 11,000 potential minor adverse events over a one-year period. The health system estimates that it has realized $4.7 million in  savings from major and minor medication error prevention since July 2018. 

Houston Methodist

Pharmacists at Houston Methodist health system, which encompasses seven hospitals, eight emergency care centers, and a network of more than 7,000 physicians, are using VigiLanz to streamline workflows and communication related to antibiotic use, and to better track and monitor antimicrobial stewardship initiatives. For example, pharmacists receive real-time alerts from VigiLanz whenever rapid diagnostic test results come back positive for gram-negative bloodstream infections. This new workflow has significantly improved patient care, with benefits that include shorter lengths of stay and a 43 percent cost reduction in mean hospital costs per patient (costs fell from $45,709 to $26,162 per patient), according to a Houston Methodist study published in the Archives of Pathology & Laboratory Medicine.

Antelope Valley Hospital

Pharmacists at the 420-bed hospital in California are using VigiLanz for several purposes, including to increase the capture of grouped antimicrobial-related interventions. As a result, the hospital’s cost savings increased from $2.8 million in 2016 to more than $3.6 million in 2017. The hospital also uses VigiLanz to progressively eliminate inappropriate antimicrobial use and reduce days of exposure. The hospital also estimated cost savings due to avoidance of adverse events at more than $576,000 in 2017. In 2016 and 2017, the emergency department alone documented more than $100,000 in savings.

Adventist Health and Rideout

Healthcare providers at the nonprofit community-based health system in California are using VigiLanz’s real-time alerts to flag issues related to antibiotic prescribingfor example, if there is a mismatch between the medication ordered and the patient’s condition. The continued focus on appropriate use of antibiotics, and on the de-escalation of antibiotic use when appropriate, has improved patient care and led to significant cost reductions. The hospital is now meeting national standards for antibiotic utilization, and annual antibiotic usage expenditures have fallen $500,000 per year.

 

To learn more about how VigiLanz could help enhance patient care at your hospital, contact us today. To receive your custom savings information, please check out our economic value tool .

 

VigiLanz Releases New Survey That Reveals Hospitals’ Top Safety Challenges and COVID-19’s Impact on Safety Priorities

For the first time in three years, hospital leaders say improving safety is a higher strategic priority than improving efficiency and reducing costs

MINNEAPOLIS, April 28, 2021 — VigiLanz, a clinical surveillance company, today released findings from their third annual hospital patient safety survey. The independent survey of 100 hospital and health system leaders, conducted in March 2021 by Sage Growth Partners, reveals significant year-over-year changes in how hospital leaders are prioritizing and approaching patient and staff safety.

For the first time in three years, hospital leaders said patient safety is a higher strategic priority than improving efficiency and reducing costs. Hospital leaders also said they are placing more emphasis on decreasing hospital-acquired infections (HAIs) and improving staff safety in 2021 than in years prior.

The full results are included in VigiLanz’s new Hospital Patient Safety Report 2021. Key findings include:

For the first time since 2019, improving patient safety is a higher strategic priority among hospital leaders than increasing efficiency and reducing costs.

  • Hospital leaders were more likely to select improving patient safety as a top strategic priority than increasing efficiency and reducing costs (57% said improving safety was in their top three strategic priorities, while only 50% said improving efficiency and reducing costs was). Hospital leaders were most likely to select delivering high quality care as one of their top three strategic priorities (77%).
  • The percentage of hospitals leaders who selected improving patient safety as a top three strategic priority has steadily increased over the past three years (40% in 2019, 50% in 2020, and 57% in 2021).
  • The percentage of hospital leaders who selected increasing efficiency and reducing costs has steadily decreased over the past three years (60% in 2019, 53% in 2020, and 50% in 2021).

Note: Other strategic priorities survey respondents could select included driving patient engagement (39%), focusing on ethics and compliance (5%), focusing on revenue improvement (16%), gaining market share (19%), investing in technologies (3%), managing population health (10%), and participating in alternative payment models (2%).

Hospital-acquired infections (HAIs) are hospitals’ top safety challenge; however, hospital leaders are growing more confident in their infection prevention capabilities.

  • Hospital leaders were most likely to select HAIs as their top safety challenge (30%), followed by medication errors (19%), and falls (16%).
  • Significantly more hospital leaders said they are extremely confident that their hospital can respond to an infectious disease of viral outbreak as soon as a patient presents symptoms in 2021 than in 2020 (44% vs. 27%).
  • Ninety-five percent said the pandemic has made infection prevention a higher hospital priority.

Protecting staff is a new top safety improvement priority for hospitals, and the pandemic is a key driver.

  • Hospital leaders were most likely to select improving staff safety as their top safety improvement priority (39%), followed by reducing HAIs and HACs (23%), reducing falls and other accidents (15%), and reducing medication errors (10%).
  • Ninety-one percent said the pandemic made improving staff safety a higher priority, and 41% said their hospital lacked adequate PPE during the pandemic.

The pandemic led to an increase in antibiotic use and medication errors within hospitals.

  • Forty-nine percent of hospital leaders said the pandemic led to an increase antibiotic prescriptions.
  • Twenty-one percent said the pandemic led to an increase in medication errors.

More hospital leaders are turning to clinical surveillance technologies to address safety challenges.

  • Ninety-five percent of hospital leaders said clinical surveillance either probably or definitely improves patient safety.
  • Most said clinical surveillance tools help identify potential infections and outbreaks (85%), safety events (85%), medication errors (70%), and antibiotic overuse (70%).
  • Sixty-nine percent said they already use the technology or plan to implement it in the next two years.

“Hospitals are facing new and unexpected challenges, and this is transforming how hospital leaders think about safety and how they prioritize it,” said VigiLanz Chairman and CEO David Goldsteen, MD. “For the first time in three years, hospital leaders are saying that improving patient safety is a higher priority than increasing efficiency and reducing costs. The pandemic revealed safety gaps and vulnerabilities, and the survey findings show that hospitals are moving quickly to address these problems with new technologies and initiatives that will have a long-lasting, positive impact.”

VigiLanz was recently recognized as Best in KLAS for Infection Control and Monitoring and Pharmacy Surveillance in the “2021 Best in KLAS: Software and Services” report. Over the past four years, VigiLanz has earned 10 KLAS awards for its solutions.

 

Methodology

VigiLanz commissioned Sage Growth Partners, a healthcare consultancy, to conduct the independent survey of 100 hospital and health system leaders in March 2021. Respondents included pharmacy executives (28%), infection prevention executives (22%), chief executive officers (13%), chief medical officers (12%), chief nursing officers (9%), and quality executives (7%). For more demographics and methodology, download the full report.

 


About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EMR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

 

Media Contact

Boh Hatter
(410) 534.1161
bhatter@sage-growth.com

VigiLanz Launches Intelligent Event Reporting Suite, Expands #1 Rated Clinical Surveillance Platform Impacting Patient Safety, Risk, Compliance, and Patient Relations

Automated event detection, expedited documentation, and enterprise-wide visibility help hospitals and health systems improve safety and reduce risks

MINNEAPOLIS, April 7, 2021VigiLanz, a clinical surveillance company, today announced the launch of three new event reporting solutions built on VigiLanz’s award-winning enterprise software platform. The new solutions, VigiLanz Risk and Claims, VigiLanz Compliance, and VigiLanz Patient Relations, complement VigiLanz’s existing Dynamic Safety Surveillance product to expand the platform’s benefits and improve hospitals’ bottom line by enabling them to quickly capture, monitor, and act on information, enhancing patient safety and reducing organizational risk.

Recently recognized as Best in KLAS for Infection Control and Monitoring and Pharmacy Surveillance, VigiLanz applied its more than 20 years of complex, clinical data experience to create and integrate the new solutions, which help hospitals harness their own data to make safety improvements and reduce risks. Key capabilities include automated event capture; expedited documentation through form autopopulation; and enhanced visibility into events and improvement opportunities through deep integration that results in data-rich enterprise dashboards.

“In order for hospitals to foster an overarching culture of safety, risk mitigation must be addressed for patients, visitors, and employees,” said Stacy Pur, VigiLanz’s VP of Product Development. “These solutions create a canopy of protection for hospitals and their patients. This allows a system-wide approach to reducing risks and improving patient satisfaction, while also saving time. Enhanced visibility, highly targeted notifications, expedited documentation, and easy escalation processes are just a few of the benefits hospitals will experience.”

Want more information on our event reporting solutions?

About the solutions:

VigiLanz Dynamic Safety Surveillance
VigiLanz optimizes safety event reporting through real-time alerts, auto-detection of events, comprehensive management and investigation tools, automated escalation, and a full library of analytics and reporting capabilities.

VigiLanz Risk and Claims
VigiLanz streamlines workflows throughout the entire lifecycle of claims and litigation events and identifies risk-reduction and damage-control opportunities. Key benefits include the ability to easily enter, manage, and escalate claims and budgets; analyze department-specific and enterprise-wide data; and continuously improve by mitigating risks and preventing future incidents.

VigiLanz Compliance
VigiLanz helps prevent, detect, and resolve illegal or unethical conduct and promotes a culture of ethical practice. Features include automated violation notifications, comprehensive management and escalation tools, and department-specific and enterprise-wide reports and analytics.

VigiLanz Patient Relations
VigiLanz streamlines the management of patient and visitor feedback, identifies patient satisfaction improvement and service recovery opportunities, and optimizes value-based reimbursement through simplified workflows, escalation tools, and enterprise-wide reporting.

“The event reporting solutions could not have been launched at a better time, as hospitals are working tirelessly to improve care during the COVID-19 pandemic and implement lessons learned from it,” said David Goldsteen, VigiLanz’s CEO. “We’re proud of our ability to continually raise the bar for clinical surveillance, and put it into the hands of more healthcare workers. We’re supporting more efficient workflows and maximizing their resources, while also helping them improve care and reduce risks.”

Learn more about the new and expanded solutions at VigiLanzcorp.com.

VigiLanz earned Best in KLAS in the “2021 Best in KLAS: Software and Services” report, released February 2, 2021. Over the past four years, VigiLanz has earned 10 KLAS awards for its solutions.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.

Enhancing Patient Safety Saves Hospitals Millions: Learn How Much Yours Could Save

As COVID-19 and the unprecedented patient care challenges it brought to healthcare organizations recede, hospitals are still reeling from financial strains caused by the pandemic. The AHA estimates that hospitals will lose between $53 billion and $122 billion by the end of this year due to residual effects of COVID-19, depending on vaccine distribution and return of patient volumes.

Still, this is no time for hospitals to hit the brakes on patient safety improvements, even if stepping up patient safety initiatives may seem challenging in the face of significant financial losses. In fact, patient safety and a healthier bottom line go hand-in-hand; if you improve patient safety, your margins will also improve, and for hospitals to return to pre-pandemic patient volumes, it will be vital for hospitals to demonstrate that patient safety is a priority.

Calculating the Value

Healthcare consultancy Sage Growth Partners recently conducted an economic value assessment of the patient-safety enhancing features and functionalities of our clinical surveillance platform.

The assessment—which is based on metrics and reports from peer-reviewed studies, journals, government databases, and other sources—determines a hospital’s potential savings from implementing VigiLanz. The evaluation is customized based on factors such as annual inpatient admissions, number of staffed beds, and daily census.

The assessment found that most hospitals can save millions of dollars by implementing VigiLanz. For example, a small hospital with 50 staffed beds, 3,000 annual admissions, an average daily census of 30, and a bed utilization rate of 50 percent could experience $1.3 million in savings. A large hospital, with 900 staffed beds, 40,000 annual admissions, an average daily census of 700, and a bed utilization rate of 80 percent, could gain $15.5 million in savings.

Hospitals can input their own unique data in order to instantly receive a free, customized report. The report shows the total economic impact the hospital could experience, and it breaks that impact down by potential:

  1. Cost savings, due to faster and more proactive identification of opportunities to cut costs, such as IV to PO conversions and more optimal management of high-cost drugs.
  2. Cost avoidance, due to fewer costly events such as hospital acquired infections or conditions, acute kidney injuries due to antibiotic use, adverse drug events, readmissions, and return visits to the emergency department.
  3. Returned resources, the value of time saved by transitioning from manual to automated processes.

The tool also provides a breakdown of savings by area, such as pharmacy, infection prevention, and safety and quality.

To learn more and to get your custom savings report, please check out the tool. If you have any questions or are interested in learning more about how your hospital can use VigiLanz to improve patient safety and your bottom line, contact us today.

VigiLanz Ranked No. 1 by KLAS Research for Infection Control and Monitoring and Pharmacy Surveillance for Fourth Straight Year

The clinical surveillance company most trusted by hospitals is recognized as Best in KLAS, totaling 10 KLAS awards over 4 consecutive years

MINNEAPOLIS – Feb. 2, 2021 – VigiLanz, a clinical surveillance company, today announced that it has earned 2021 Best in KLAS designations from KLAS Research for Infection Control and Monitoring and Pharmacy Surveillance. This is the fourth year VigiLanz has been recognized by KLAS as a leader across both areas, and brings its total count of KLAS awards to 10. VigiLanz was also recognized in previous years in the Antimicrobial Stewardship category, which KLAS folded into Pharmacy Surveillance this year.

VigiLanz products earned Best in KLAS across two segments in the “2021 Best in KLAS: Software and Services” report, released on February 2:

Infection Control and Monitoring

Earning a score of 93.7, VigiLanz’s Dynamic Infection Control Monitor is a seamless, real-time automated monitoring system that works with an organization’s EHR. Its exception-based alert system puts all patient records under continuous surveillance to alert decision makers in real time of potential infections, MDROs, isolation candidates, organism clusters, conditions of concern, and reportable infections. The surveillance is based on a sophisticated set of customizable rule engines.

“VigiLanz has been really good through the COVID-19 crisis because every time we need a new test, I just email the vendor, and they add it to the product. The vendor’s help has been a blessing.”

  • Physician, August 2020, klasresearch.com

Pharmacy Surveillance

Earning a score of 91.1, VigiLanz’s Dynamic PharmacoVigilance product acts as a bridge between a hospital’s pharmacy and lab information systems, automating the comparison of patients’ drug usage with lab results, then presenting the potential for adverse drug event reduction. Based on the system’s built-in rule sets or hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make appropriate drug therapy decisions.

“The product is extremely easy to use, and that has to be a big part of our success. Something that is hard to use or clunky wouldn’t work for our teams’ workflow. It doesn’t matter how good the quality of the material is; a clunky product wouldn’t work because we are moving at such a fast pace.

  • Manager, June 2020, klasresearch.com

In addition, VigiLanz’s Antimicrobial Stewardship product monitors antimicrobial therapy to ensure appropriate use, including unnecessary antibiotic therapy, de-escalation opportunities, positive rapid diagnostic test results, drug-bug mismatches, and opportunities for antibiotic “time-outs.” The Antimicrobial Stewardship dashboard shows usage and resistance trends across the organization, is Meaningful Use 3 certified, and is certified by the National Healthcare Safety Network for easy, direct reporting on antibiotic use.

“I have found VigiLanz to be really helpful with their ability to fine-tune a rule and screen out a lot of noise. So we are getting exactly what we need. We can tease out geography, look at specific organisms, or look at different time frames. This is very powerful and very easy to do in the system.”

  • Director, January 2020, klasresearch.com

“In what’s proven to be a particularly challenging year for our hospital customers, we’re extremely proud to continue our recognition by KLAS four years in a row,” said VigiLanz Chairman and CEO David Goldsteen, MD. “We know our customers rely on us when they need it most—whether that’s triaging COVID-19 cases, monitoring the use of specific pharmaceuticals during a shortage, or saving clinicians time providing real-time alerts and reports so they can focus more on patients. It’s our job to help hospitals keep patients safe, and we’re honored to see the glowing feedback from this past year.”

Best in KLAS is a recognition given to vendors for outstanding efforts to help healthcare professionals deliver better patient care. The Best in KLAS designation is reserved for the software and services market segments that have the broadest operational and clinical impact on healthcare organizations. Rankings are based on customer surveys of North American healthcare leaders, administrators, clinicians, and others who interact with the solutions.

Selected commentary collected about VigiLanz Infection Control and Monitoring and Pharmacy Surveillance, January 2021  © 2021 KLAS. Visit klasresearch.com for a complete view.

###

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers and payers to be heard and counted. Working with thousands of healthcare professionals, KLAS gathers insights on software, services and medical equipment to deliver timely reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based clinical surveillance solutions. The firm is focused on aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes and support preventive care. VigiLanz supports a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to real-time inpatient and outpatient care.